News

Medical Devices

America Will Win the COVID-19 Coronavirus War: Jeff Kagan

Jeff Kagan | Equities.com |

America will get through the Covid-19 or coronavirus crisis. In fact, so will the entire world. We will develop vaccines like the flu shot and effective treatments. Hydroxychloroquine may be a possible answer.


Eko Devices Gets FDA Clearance on Atrial Fibrillation and Heart Murmur Detection Algorithms

Edward Kim | Equities.com |

The new algorithms create the first AI-powered stethoscope to screen for serious heart conditions


Jeff Kagan: Top CEO Innovators Who Are Changing the World

Jeff Kagan | Equities.com |

This is my list of the Top CEO Innovators who are changing our world.


Smith & Nephew's Single-Use Wound Treatment Shown To Be Superior to Traditional Care

Edward Kim | Equities.com |

The PICO system reduced wound area, depth and volume compared with traditional negative pressure wound therapy.


3 Stocks to Watch Ahead of Earnings

Harry Boxer | Equities.com |

These three health and technology stocks are seeing technical strength ahead of upcoming earnings.


University of Alberta Researchers Identify a New Gene that Causes Glaucoma

Edward Kim | Equities.com |

We're following several companies pursuing next generation glaucoma treatments.


Eyenovia Shows Positive Phase 3 Results in Pupil Dilation Device

Edward Kim | Equities.com |

80 million annual exams in the US involve mydriasis (pupil dilation)


BioCardia Submits FDA Application for New Steerable Cardiovascular Introducer

Edward Kim | Equities.com |

The AVANCE is designed to introduce cardiovascular catheters into the heart, including via the interatrial septum (Image: BioCardia)


Generex Acquires Majority Stake in Olaregen Therapeutix to Enter Wound Healing Market

Edward Kim | Equities.com |

Olaregen's Excellagen (flowable dermal matrix) is FDA approved for wound management in multiple indications (Image: Olaregen Therapeutix)


Vapotherm's $60 Million IPO Expected Next Week for Respiratory Distress Treatment Systems

Edward Kim | Equities.com |

Company markets the only mask-free, clinically validated alternative to the standard of care for respiratory distress (Image: Vapotherm)


Sponsored Financial Content

Market Movers